ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences

ANI Pharmaceuticals (NASDAQ: ANIP) announced that CEO Nikhil Lalwani and CFO Stephen Carey will present at two key conferences.

Rhea-AI Impact

(Moderate)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Tags

conferences

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

05/20/2022 - 06:50 AM EDT

BAUDETTE, Minn.--(BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at two upcoming conferences as follows:

H.C. Wainwright Global Investment Conference (Virtual)

Date:	Tuesday, May 24, 2022

Time:	On Demand, 7:00 a.m. ET

Webcast:	Click Here

Jefferies Healthcare Conference (New York City, NY)

Date:	Thursday, June 9, 2022

Time:	11:30 a.m. ET

Webcast:	Click Here

The webcasts will be accessible via the Company’s website at www.anipharmaceuticals.com, in the Investors section under Events and Presentations.

About ANI

ANI Pharmaceuticals is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin® Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit www.anipharmaceuticals.com.